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Tracheostomy in intensive care unit patients
can be performed without bleeding
complications in case of normal
thromboelastometry results (EXTEM CT)
despite increased PT-INR: a prospective pilot
study
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Abstract
Background: Coagulopathy is often accompanied by prolongation of prothrombin time (PT) in septic and
nonseptic patients in intensive care unit (ICU). The conventional way to correct the coagulopathy is to administer
fresh frozen plasma (FFP) before invasive procedures to minimise the risk of bleeding. However, prolonged PT can
be present even in hypercoagulation status, resulting in unnecessary administration of FFP. In the present study, we
have assessed the reliability of thromboelastometry in case of prolonged PT and the relationship to bleeding
complications during surgical tracheostomy.
Methods: The study was conducted during the period between April 2013 and April 2014 in patients undergoing
surgical tracheostomy. Coagulation status was assessed using PT, and the status was reassessed by
thromboelastometry for prolonged PT. Tracheostomy was performed in patients with normal thromboelastometry
results without administering FFP.
Results: Tracheostomy was performed in total 119 patients. Normal value of PT as measured by international
normalized ratio (INR) ≤ 1.2 was found in 64 (54 %) patients, while prolonged INR > 1.2 was found in 55 (46 %)
patients. Patients with INR ≥ 1.3 (with INR min- 1.3, max- 1.84, and median- 1.48) were further analysed by
thromboelastometry. Despite prolonged INR, thromboelastometry results were in normal ranges in all cases except
one. With normal thromboelastometry, tracheostomy was performed safely without any bleeding complication.
Conclusions: Surgical tracheostomy in septic and nonseptic patients can be performed without bleeding
complications in case of normal thromboelastometry results (EXTEM CT) despite increased PT-INR. This method can
help physicians to reduce unnecessary administration of FFP in patients.
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Background
Coagulopathy is a well-known phenomenon among inten-
sive care unit (ICU) patients undergoing surgical proce-
dures such as tracheostomy [1]. It is often accompanied
by prolonged standard coagulation tests such as pro-
thrombin time (PT, international normalized ratio, INR).
However, prolonged PT-INR does not necessarily indicate
hypocoagulation status; it might even accompany hyper-
coagulation status [2]. According to the recent guidelines
of the European Society of Anaesthesiology (ESA) for the
management of perioperative bleeding [3], correcting pro-
longed PT-INR up to 1.5 is not recommended. However,
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in practice, even if the PT-INR is below or over 1.5, many
physicians try to correct this coagulopathy, usually by ad-
ministering fresh frozen plasma (FFP) prior to the planned
surgical intervention including tracheostomy to reduce
the risk of bleeding. Indeed, the consequences of eventual
bleeding can be life threatening, even when PT-INR is
below 1.5. The limitation of the PT-INR test is its inability
to determine the role of other blood components, such as
platelets and erythrocytes, which play important roles in
the initiation of blood coagulation. Moreover, the PT-INR
does not provide any information on other coagulation
phases, such as propagation, clot strength and fibrinolysis,
which can be decreased or increased despite of normal or
pathologic PT-INR of 1.5. Therefore, surgery always re-
mains associated with the bleeding risk irrespective of pa-
tients’ PT-INR status. Rotational thromboelastometry
(ROTEM) as viscoelastic method may be a better method
in this regard and can be used for differentiating hypocoa-
gulation from hypercoagulation situations [2] thereby
assessing coagulation status better than the PT-INR. Thus,
ROTEM could help in providing aimed administration of
FFP and other drugs to patients who are at risk of bleeding
even before surgical complication. Furthermore, with such
a reliable method of coagulation monitoring, it would be
possible to reduce transfusion of FFP and minimise risks
associated with FFP administration [4]. In this study, our
objective was to find out whether surgical tracheostomy
can be done safely and without bleeding complication in
patients with normal ROTEM-EXTEM results despite
prolonged PT-INR in ICU patients.
Methods
This prospective study was approved by the Ethics Com-
mittee for Multi-Centric Clinical Trials of the University
Hospital Motol. In all unconscious patients informed
consent was obtained from family members. One hun-
dred nineteen patients, who underwent planned surgical
tracheostomy at the Department of Anaesthesiology and
Intensive Care Medicine, Motol University Hospital in
Prague between April 2013 and April 2014, were en-
rolled for this study. Blood coagulation status was
assessed by PT–INR, analysed with CA-7000 automated
coagulation analyser (Sysmex Co., Kobe, Japan). Arterial
blood was used for this analysis. In the cases where PT-
INR was prolonged over 1.2, while the platelets count
was higher than 50 × 109/L and activated partial
thromboplastin time was normal (APTT-INR 0.8-1.18),
ROTEM-EXTEM (TEM International GmbH, Munich,
Germany) was also performed. Tracheostomy without
prior administering FFP was performed in patients with
at least minimal values of normal range for EXTEM re-
sults (coagulation time - CT, clot formation time - CFT,
alpha-angle, A10 – amplitude in mm 10 min after CT,
maximum clot firmness - MCF, lysis index - LI30 and
LI60). In order to correct coagulopathy before tracheos-
tomy, 4 FFP was administered only in those cases where
ROTEM revealed pathological values in EXTEM CT.
ROTEM was not re-assessed after the intervention.
Bleeding was assessed during tracheostomy as well as
24 h after the procedure. The following three conditions
were considered as complication: (i) surgeon performing
tracheostomy assessed bleeding as major or nonstandard,
(ii) surgical revision was necessary to stop bleeding, or (iii)
decrease in haemoglobin levels during 24-hour postopera-
tive period because of tracheal bleeding. We also identified
the cause for which the patients were brought to ICU and
accordingly, divided them into two groups as septic (pa-
tients who were admitted to ICU because of severe sepsis)
and nonseptic (admitted for a reason other than sepsis).
Coagulation status was compared between the two study
groups not only to find out whether there was any differ-
ence in ROTEM-EXTEM (tissue factor-triggered extrinsic
pathway) findings between two groups, but also to check
whether prolonged PT- INR was connected to sepsis in the
participants.
Statistical analysis
For data analysis, we used GraphPad Prism 6.0 statistics
program. While descriptive statistics was used to deter-
mine minimal, maximal and median values, unpaired two
tailed t-test was used to compare EXTEM parameters and
coagulation parameters between PT-INR 1.21-1.29 and
PT-INR >1.3 groups, and between nonsepsis and sepsis
groups (p < 0.05 was considered as significant).
Results
During the study period (April 2013–April 2014), oto-
rhinolaryngologist surgeons performed 119 tracheosto-
mies in those ICU patients who needed artificial
mechanical ventilation even after tenth day of their hos-
pitalisation. Normal value of PT-INR ≤ 1.2 was found in
64 (54 %) patients, while prolonged PT-INR over 1.2 was
found in 55 (46 %) patients (Fig. 1). ROTEM-EXTEM
was performed only when PT-INR was ≥ 1.3 (PT-INR
min 1.3, max 1.84, and median 1.48), because neither
the surgeon nor the physician would correct PT-INR
below 1.3. We found 28 (51 %) patients with PT-INR
value between 1.21–1.29 and 27 (49 %) patients with
PT-INR ≥ 1.3 (Fig. 1). Except in one patient (EXTEM CT
of 99 s, PT-INR 1.4, APTT-INR 1.18), EXTEM results
were in normal ranges or hypercoagulable in almost all
patients with PT-INR ≥ 1.3 (Table 1). Tracheostomy was
performed safely without any bleeding complication in
patients with normal EXTEM results.
While analysing these ICU patients for the cause of
hospitalisation, we found that sepsis counted for only
25 % patients in the group with PT-INR ≤ 1.2; nonseptic
condition was the cause of hospitalisation in the rest
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75 % patients in that group (Fig. 2). However, in the
group with PT-INR > 1.2, 47 % patients were hospitalised
for sepsis, while 53 % for nonseptic conditions (Fig. 2).
In the subgroup with PT-INR 1.21–1.29, 36 % patients
were with sepsis, while 64 % were with nonseptic condi-
tions (Fig. 3). Interestingly, in the subgroup with PT-
INR ≥ 1.3, nonseptic condition was present in only 40 %,
patients with sepsis increased to 60 % (Fig. 3). However,
we did not find any statistical difference between the sep-
tic and nonseptic initiation phase of coagulation (p =0.6)
as represented by CT of ROTEM-EXTEM in the group
with PT-INR ≥ 1.3 (Fig. 4). As well, comparing overall sep-
tic group to nonseptic group there was no significant
difference in parameters of CFT, alpha angle (p > 0.05),
but when looking closer to cloth strength, parameter A10
was borderline (p = 0.056), MCF was significantly higher
in septic patients (p < 0.05) and fibrinolysis was signifi-
cantly decreased in sepsis (p < 0.05) represented by param-
eters LI60 and ML.
Discussion
Coagulopathy in ICU patients is often reported in litera-
ture, but there is an ongoing debate about its pathophysi-
ology. Kinasewitz et al. described that the consumption
and depletion of endogenous haemostasis factors in sepsis
result in the prolongation of PT-INR [5]. On the other
hand, platelets are often activated by inflammatory process
[6] together with increased level of fibrinogen [7]; this
situation can often lead to hypercoagulation and fibrin de-
position connected to organ dysfunction [8–10]. However,
in inflammation and sepsis hypercoagulation can quickly
change to hypocoagulation, while PT-INR itself remains
unchanged. As PT-INR does not take into account all co-
agulation factors, thromboelastography/thromboelastome-
try (TEG/ROTEM) seems to be a better method for
differentiating between those two stages (hyper vs. hypo-
coagulation) in septic and nonseptic patients [2, 11–13].
Our results of EXTEM say that if parameters such as CT,
CFT, alpha angle, A10, MCF, LI30, LI60, ML are in normal
range or hypercoagulable, surgical procedure such as
tracheostomy can be done safely. These findings are similar
to recently published data of Greene et al. demonstrating
that thromboelastometry measures of clot firmness
(EXTEM A10, A20, and MCF) are superior to platelet
Fig. 1 Frequency of patients with laboratory coagulopathy
represented by INR (INR - International normalized ratio)
Table 1 ROTEM-EXTEM and laboratory coagulation parameters in examined patients
EXTEM parameters INR 1.21-1.29 (mean ± SD) INR≥ 1.3 (mean ± SD) Nonsepsis (mean ± SD) Sepsis (mean ± SD)
CT (seconds) 58.60 ± 14.01 60.79 ± 7.58 ns 58.75 ± 10.42 61.92 ± 7.29 ns
CFT (seconds) 50.40 ± 21.41 67.05 ± 24.98 ns 71.17 ± 27.75 56.00 ± 19.8 ns
α angle (degrees) 80.60 ± 4.04 76.79 ± 4.67 ns 76.50 ± 5.27 78.67 ± 4.8 ns
A10 (mm) 69.00 ± 9.67 65.16 ± 8.02 ns 62.75 ± 8.98 69.17 ± 6.44 p=0.056
MCF (mm) 73.2 ± 8.17 70.47 ± 6.02 ns 68.33 ± 6.91 73.75 ± 4.75 *
LI30 (%) 99.60 ± 0.55 99.63 ± 0.59 ns 99.58 ± 0.67 99.67 ± 0.49 ns
LI60 (%) 94.00 ± 4.12 96.47 ± 3.47 ns 93.50 ± 3.56 98.42 ± 1.51 ***
ML (%) 9.00 ± 5.61 6.21 ± 4.93 ns 9.67 ± 4.89 3.92 ± 3.48 **
Laboratory parameters
Fibrinogen g/L 4.57 ± 0.88 4.73 ± 6.62 ns 4.72 ± 0.53 4.68 ± 0.79 ns
Platelets(x109/L) 209.4 ± 132.5 160.1 ± 77.18 ns 164.8 ± 101.1 175.9 ± 81.99 ns
CT – coagulation time, time from the start of the sample run to the first detectable clot formation (amplitude =2 mm); CFT – clot formation time, time from CT to the
clot amplitude of 20 mm (to specify the kinetics of the clot development); α angle, angle between the trace and the x-axis; A10 clot firmness (in mm amplitude) at the
respective, time point after CT
MCF- maximum clot firmness; LI30 and LI60 - Lysis Index at time 30 and 60 min after CT; ML - maximum lysis during whole measuring time of (90 min)
Normal values for ROTEM: EXTEM – CT 38–79 s, CFT 34–159 s, α angle 63-83°, MCF 50–72 mm, LI30 0-7 %, LI60 0-15 %; Fibrinogen- 1.8-4.2 g/L, Platelets count
– 150-400x109/L
ns - means nonsignificant difference between two groups p > 0.05 * means significant difference between two groups p < 0.05 ** means significant difference be-
tween two groups p < 0.01 *** means significant difference between 2 groups p < 0.001
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count in predicting bleeding in patients with severe
thrombocytopenia [14]. Our finding of decreased later fi-
brinolysis in septic patients represented by LI60 and ML is
in accordance with similar results of Amazik at al. [15].
To the best of our knowledge, the present study is the
first report where ROTEM-EXTEM was used as a global
coagulation test for evaluating of coagulation status be-
fore surgical tracheostomy and comparing to standard
coagulation tests. Here we provided mostly the descrip-
tive statistics (Figs. 1, 2 and 3), because it would be un-
ethical to look for a point in ROTEM at which the
patient would start bleeding as bleeding is a life-
threatening risk. Data obtained from descriptive analysis
are sufficient to provide both clinical and forensic sup-
ports to the surgeon as well as to the physician taking
care of the patient and that can lead to decreased ad-
ministration of unnecessary FFP administration.
When EXTEM CT was pathologic, 4 units FFP were
administered to the patient before tracheostomy. As we
did not do control ROTEM, we do not know if FFP was
able to correct prolonged CT. However, many authors
say that FFP is not able to correct a mild increased PT-
INR of 1.3 to 1.8 [16–18]. There was only one case when
EXTEM CT was prolonged (CT of 99 s, PT-INR was 1.4
and APTT-INR was 1.18) out of 27 ROTEM tests per-
formed in the subgroup of PT-INR ≥ 1.3.
Figure 1 shows that among the 119 patients who under-
went tracheostomy, normal PT-INR (≤1.2) was present in
54 % of cases and pathologic PT-INR (>1.2) in 46 % of
cases. The group with pathologic PT-INR was further di-
vided into two subgroups with PT-INR 1.21–1.29 and PT-
INR ≥ 1.3. This is because, in practice, a physician would
not correct PT-INR up to 1.29; hence, we performed
EXTEM only for the subgroup with PT-INR ≥ 1.3. Inter-
estingly, the number of patients was almost identical in
both subgroups, i.e., 51 % of patients with PT-INR over
1.2 belonged to the group with PT-INR 1.21–1.29 and
49 % belonged to the other group (Fig. 1).
Next we attempted to find whether any association ex-
ists between the prolonged PT-INR and the reasons for
hospitalisation. Based on our analysis, we divided the pa-
tients into two groups: (i) septic group and (ii) nonseptic
group (Table 2). Nonsepsis patients prevailed in the
study group with PT-INR ≤ 1.2, while the group with
PT-INR > 1.2 had 53 % nonseptic patients and 47 % septic
patients (Fig. 2). Therefore, it is evident that coagulopathy
with prolonged PT-INR was almost identically present in
Fig. 2 Frequency of INR in nonseptic and septic group of patients
Fig. 3 Frequency pathologic INR in nonseptic and septic group
of patients
Fig. 4 Coagulation time (CT) ROTEM parameter in nonsepsis and
sepsis group of patients (INR≥ 1.3). There is no statistical difference
between CT of nonseptic and septic patients; p = 0.6
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septic and nonseptic patients. Interestingly, in the sub-
group of PT-INR 1.21–1.29, nonsepsis prevailed in 64 %
of patients over 36 % sepsis patients. However, when PT-
INR exceeded 1.29, the coagulopathy proportion turned
around with 60 % patients with PT-INR ≥ 1.3 found in the
septic group; the residual 40 % were in nonseptic group
(Fig. 3).
The normalization of EXTEM CT despite an increased
PT-INR value might be due to the presence of sepsis
with increased tissue factor expression on circulating
monocytes [15, 19, 20] and this cannot be detected in
plasmatic coagulation tests such as PT-INR since the
cells are removed by centrifugation, however, CT in
ROTEM can be shortened in this case. Coagulation time
of EXTEM in PT-INR ≥ 1.3 subgroup did not differ sta-
tistically (p > 0.05) between those two groups; it was, in
fact, in the normal range. No patients had bleeding com-
plication in either group despite the prolonged PT-INR,
which represent mainly clotting factor deficiency. This
could be explained by the fact that despite the coagula-
tion factor deficiency in ICU patients, other substances
of blood important in coagulation such as platelets, fi-
brinogen, etc., might compensate for factor insufficiency.
Beiderlinden at al. found that bleeding incidence dur-
ing and following dilatational tracheostomy was higher
in patients with prolonged APTT and with platelets
below 50 × 109/L [21]. This may be true as platelets
below 50 × 109/L are generally connected with prolonged
bleeding time and impaired primary hemostasis. That is
why our patients had at least this number of platelets.
Notably, platelet dysfunction due to antiplatelet drugs
cannot be detected by ROTEM. However, Greene et al.
demonstrated that ROTEM clot firmness (A10 or MCF
in INTEM or EXTEM) is superior to platelet count in
predicting bleeding in pediatric patients
with ITP (Immune Thrombocytopenia) and severe
thrombocytopenia (<30x109/L) [14]. Furthermore, Fayed
et al. reported that a ROTEM-guided transfusion proto-
col in patients undergoing liver transplantation can
avoid 75 % of platelet transfusions in patients with a
platelet count < 50 × 109/L without increased bleeding
rate [22]. Therefore, clot firmness (A10 or MCF) should
be considered in addition to CT in particular in patients
with thrombocytopenia. When it comes to APTT, we ex-
cluded patients with prolonged APTT for the following
reasons: (i), extrinsic pathway of coagulation initiation
prevails in vivo, as described in cellular model of coagu-
lation; (ii) in our chronic ICU patients PT prolongation
is more common than APTT; (iii) when PT is pro-
longed, prothrombin complex can be used instead of
FFP. Prolonged APTT is a more complex concern as it
can be caused by heparin or hemophilia but we plan to
look closer to this problem in the future.
The limitation of the study is the fact that at the time
of performed tracheostomy the primary cause and rea-
son for admission to ICU had almost resolved (tracheos-
tomy is usually performed after tenth day of artificial
ventilation) and patients from both groups were becom-
ing alike, meaning becoming patients with ICU coagu-
lopathy. That might be the reason why there is little and
no statistically significant difference in CT-EXTEM pa-
rameters between groups. Another limitation of the
study is the number of subjects involved in the study but
as a pilot study it can be useful for other researchers also
in other medical fields.
Conclusions
Based on the above findings, we conclude that throm-
boelastometry (ROTEM-EXTEM) is a reliable method
for assessing coagulation status in patients in ICU and it
is superior to standard coagulation prothrombin time
(PT-INR). Thromboelastometry can differentiate hypo-
coagulation status from normal/hypercoagulation status
and thus even in case of prolonged PT-INR surgical
tracheostomy can be performed safely without bleeding
complication in septic and nonseptic patients provided
Table 2 Causes of nonsepsis and sepsis which brought patients
to ICU
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that EXTEM parameters are at least normal. This
method also supports physicians in reducing unneces-
sary FFP administration used preventively to minimise
bleeding risk in patients with prolonged PT-INR.
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